Manitoba getting 1,100 doses of newly approved COVID-19 antiviral treatment
Manitoba will be getting 1,100 doses of the Pfizer COVID-19 antiviral treatment called Paxlovid.
A tweet from the Manitoba Government account on Monday said this is an initial allotment and more doses have been requested.
On Monday, Health Canada announced the approval of the drug, which is the first COVID-19 therapy that can be taken at home.
Dr. Supriya Sharma, the chief medical adviser of Health Canada, said the treatment consists of two drugs that are taken together twice per day, for five days. It is only for use after the diagnosis of COVID-19 and must be given within five days of the start of symptoms.
She added the studies submitted by Pfizer for Health Canada to review showed an effectiveness at preventing severe outcomes like hospitalization and death caused by COVID-19 by close to 90 per cent when taken within three days of symptoms showing up. The effectiveness is reduced slightly when taken five days after symptom onset to 85 per cent.
“I’ve never really liked the term game changer, but this is a really important tool that I think will provide some relief to hospitals,” said Dr. Philippe Lagacé-Wiens, a medical microbiologist at St. Boniface Hospital. “But there are a lot of warnings and caveats that come with that.”
Lagacé-Wiens said because initial supply is so limited, the impact won’t be huge on hospitals. He said it is also not a replacement for vaccination. He said the province needs to get to the point where the drug is widely available and easy to access through community pharmacies.
“At that point, for the high-risk people, it probably will make a major difference," he said. "But until we get to a really good supply chain and a testing system that works, we’re not going to see a huge difference. But it’s still really good news if you think about it.”
Lagacé-Wiens also said that because a confirmed positive test is needed to get Paxlovid, testing may need to be prioritized for people at higher risk of hospitalization and death since getting the drug early is so important.
“So this is really a great tool, but it has to be applied to the community setting in mild to moderate COVID-19 to reduce hospitalizations,” he said. “We really need to have excellent access to testing to be able to identify those people who are going to benefit from it, the ones with those risk factors we have been hearing over and over again in the pandemic because those are the ones who will benefit the most.”
Lagacé-Wiens said these populations may include people over 60, those with diabetes or lung disease or who are overweight. He also said this treatment is not approved for everyone, as children and pregnant women are not eligible. Paxlovid also has many medications that it interacts with, like birth control to antidepressants and more.
There is no word on when the first shipment of Paxlovid will arrive in Manitoba or how it will be distributed.
CTVNews.ca Top Stories
BREAKING Ontario Provincial Police arrest 64 suspects in child sexual exploitation investigation
Ontario Provincial Police say 64 suspects are facing a combined 348 charges in connection with a series of child sexual exploitation investigations that spanned the province.
AstraZeneca says it will withdraw COVID-19 vaccine globally as demand dips
AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a 'surplus of available updated vaccines' since the pandemic.
'Summer of discontent': Federal unions vow to fight new 3-day a week office mandate
Federal unions are launching legal challenges and encouraging public sector workers to file "tens of thousands" of grievances over the new mandate requiring federal workers to return to the office at least three days a week in the fall.
Toronto police seek suspect vehicle after security guard shot outside Drake's mansion
Toronto police are seeking help from the public as they continue to investigate a shooting that seriously injured a security guard outside rapper Drake's mansion.
'Ozempic babies': Reports of surprise pregnancies raise new questions about weight loss drugs
Numerous women have shared stories of 'Ozempic babies' on social media. But the joy some experience in discovering pregnancies may come with anxiety about the unknowns.
OPINION What King Charles' schedule being too 'full' to accommodate son suggests
Prince Harry, the Duke of Sussex, has made headlines with his recent arrival in the U.K., this time to celebrate all things Invictus. But upon the prince landing in the U.K., we have already had confirmation that King Charles III won't have time to see his youngest son during his brief visit.
Seafood, eat food: Calgary Stampede releases Midway menu
The Calgary Stampede has released its menu of sweet, salty and spicy treats available on the Midway for the Greatest Outdoor Show on Earth.
Boy Scouts of America is rebranding. Here's why they've changed their name
After more than a century, Boy Scouts of America is rebranding as Scouting America, another major shakeup for an organization that once proudly resisted change.
These snakes not only fake their own deaths, they use gory special effects to do it
Awards season may be over for human actors this year, but there’s no rest for some of nature’s most audacious thespians.